31 – 40 of 106
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Interpretation of conventional survival analysis and competing risk analysis : An example of hypertension and prostate cancer
(
- Contribution to journal › Article
- 2015
-
Mark
Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.
(
- Contribution to journal › Article
-
Mark
Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts
(
- Contribution to journal › Article
-
Mark
URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibers in rats.
2015) In BJU International(
- Contribution to journal › Article
-
Mark
The BJUI at the Lindau Nobel Laureates meeting
2015) In BJU International(
- Other contribution › Web publication
- 2014
-
Mark
Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.
(
- Contribution to journal › Article
-
Mark
Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?
(
- Contribution to journal › Article
- 2012
-
Mark
Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
(
- Contribution to journal › Article
-
Mark
Testosterone in prostate cancer: the Bethesda consensus.
(
- Contribution to journal › Article